Metastasectomy of Krukenberg tumors may be associated with survival benefits in patients with metastatic gastric cancer

Anticancer Research

Volumn 32, Issue 8, 2012, Pages 3397-3402

  Lu, Li Chun ^a   Shao, Yu Yun ^a,b   Hsu, Chih Hung ^a,b   Hsu, Chiun ^a,b   Cheng, Wen Fang ^a,b   Lin, Yu Lin ^a   Cheng, Ann Lii ^a,b   Yeh, Kun Huei ^a,b  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Gastric cancer; Krukenberg tumors; Metastasectomy

Indexed keywords

BEVACIZUMAB; CAPECITABINE; CETUXIMAB; FLUOROURACIL; GIMERACIL PLUS OTERACIL POTASSIUM PLUS TEGAFUR; IRINOTECAN; PLATINUM;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MALE; MEDICAL RECORD REVIEW; METASTASIS; METASTASIS RESECTION; METASTASTIC GASTRIC CANCER; MORBIDITY; OUTCOME ASSESSMENT; OVARY CARCINOMA; OVARY METASTASIS; OVERALL SURVIVAL; PREDICTOR VARIABLE; PRIORITY JOURNAL; STOMACH CANCER; SURVIVAL RATE; SYSTEMIC THERAPY;

ADULT; AGED; FEMALE; HUMANS; KRUKENBERG TUMOR; MIDDLE AGED; NEOPLASM METASTASIS; OVARIAN NEOPLASMS; STOMACH NEOPLASMS;

EID: 84865682392     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Kamangar F, Dores GM and Anderson WF: Patterns of cancer incidence, mortality, and prevalence across five continents: Defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 24: 2137-2150, 2006.
2. Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108, 2005.
3. Lim L, Michael M, Mann GB and Leong T: Adjuvant therapy in gastric cancer. J Clin Oncol 23: 6220-6232, 2005.
4. Paoletti X, Oba K, Burzykowski T, Michiels S, Ohashi Y, Pignon JP, Rougier P, Sakamoto J, Sargent D, Sasako M, Van Cutsem E and Buyse M: Benefit of adjuvant chemotherapy for resectable gastric cancer: A meta-analysis. JAMA 303: 1729-1737, 2010.
5. Bang YJ, Van Cutsem E, Feyereislova A, Chung HC, Shen L, Sawaki A, Lordick F, Ohtsu A, Omuro Y, Satoh T, Aprile G, Kulikov E, Hill J, Lehle M, Ruschoff J and Kang YK: Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (TOGA): A phase 3, open-label, randomised controlled trial. Lancet 376: 687-697, 2010.
6. Koizumi W, Narahara H, Hara T, Takagane A, Akiya T, Takagi M, Miyashita K, Nishizaki T, Kobayashi O, Takiyama W, Toh Y, Nagaie T, Takagi S, Yamamura Y, Yanaoka K, Orita H and Takeuchi M: S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (spirits trial): A phase III trial. Lancet Oncol 9: 215-221, 2008.
7. Cunningham D, Starling N, Rao S, Iveson T, Nicolson M, Coxon F, Middleton G, Daniel F, Oates J and Norman AR: Capecitabine and oxaliplatin for advanced esophagogastric cancer. N Engl J Med 358: 36-46, 2008.
8. Ajani JA, Rodriguez W, Bodoky G, Moiseyenko V, Lichinitser M, Gorbunova V, Vynnychenko I, Garin A, Lang I and Falcon S: Multicenter phase III comparison of cisplatin/S-1 with cisplatin/infusional fluorouracil in advanced gastric or gastroesophageal adenocarcinoma study: The flags trial. J Clin Oncol 28: 1547-1553, 2010.
9. Woodruff JD and Novak ER: The krukenberg tumor: Study of 48 cases from the ovarian tumor registry. Obstet Gynecol 15: 351-360, 1960.
10. Leffel JM, Masson JC and Dockerty MB: Krukenberg's tumors: A survey of forty-four cases. Ann Surg 115: 102-113, 1942.
11. Kiyokawa T, Young RH and Scully RE: Krukenberg tumors of the ovary: A clinicopathologic analysis of 120 cases with emphasis on their variable pathologic manifestations. Am J Surg Pathol 30: 277-299, 2006.
12. Yada-Hashimoto N, Yamamoto T, Kamiura S, Seino H, Ohira H, Sawai K, Kimura T and Saji F: Metastatic ovarian tumors: A review of 64 cases. Gynecol Oncol 89: 314-317, 2003.
13. Kim HK, Heo DS, Bang YJ and Kim NK: Prognostic factors of Krukenberg's tumor. Gynecol Oncol 82: 105-109, 2001.
14. Ayhan A, Guvenal T, Salman MC, Ozyuncu O, Sakinci M and Basaran M: The role of cytoreductive surgery in nongenital cancers metastatic to the ovaries. Gynecol Oncol 98: 235-241, 2005.
15. Kim WY, Kim TJ, Kim SE, Lee JW, Lee JH, Kim BG and Bae DS: The role of cytoreductive surgery for non-genital tract metastatic tumors to the ovaries. Eur J Obstet Gynecol Reprod Biol 149: 97-101, 2010.
16. Jiang R, Tang J, Cheng X and Zang RY: Surgical treatment for patients with different origins of Krukenberg tumors: Outcomes and prognostic factors. Eur J Surg Oncol 35: 92-97, 2009.
17. Cheong JH, Hyung WJ, Chen J, Kim J, Choi SH and Noh SH: Survival benefit of metastasectomy for Krukenberg tumors from gastric cancer. Gynecol Oncol 94: 477-482, 2004.
18. Schrag D, Earle C, Xu F, Panageas KS, Yabroff KR, Bristow RE, Trimble EL and Warren JL: Associations between hospital and surgeon procedure volumes and patient outcomes after ovarian cancer resection. J Natl Cancer Inst 98: 163-171, 2006.